BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hong JY, Park SY, Kim A, Cho SN, Hur YG. Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects. J Thorac Dis 2019;11:5210-7. [PMID: 32030238 DOI: 10.21037/jtd.2019.12.11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front Microbiol 2021;12:745592. [PMID: 34745048 DOI: 10.3389/fmicb.2021.745592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rahman S, Irfan M, Siddiqui MAR. Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review. BMJ Open Ophthalmol 2021;6:e000663. [PMID: 34046524 DOI: 10.1136/bmjophth-2020-000663] [Reference Citation Analysis]
3 Oh CE, Ortiz-Brizuela E, Bastos ML, Menzies D. Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. Clin Infect Dis 2021;73:e1116-25. [PMID: 33289038 DOI: 10.1093/cid/ciaa1822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Smith K, Kleynhans L, Snyders C, Bernitz N, Cooper D, van Helden P, Warren RM, Miller MA, Goosen WJ. Use of the MILLIPLEX® bovine cytokine/chemokine multiplex assay to identify Mycobacterium bovis-infection biomarkers in African buffaloes (Syncerus caffer). Vet Immunol Immunopathol 2021;231:110152. [PMID: 33227620 DOI: 10.1016/j.vetimm.2020.110152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Çavuşoğlu C, Yaşar-Duman M, Sezai Taşbakan M, Işıkgöz-Taşbakan M, Nurullah Orman M. Evaluation of the performance of QuantiFERON®-TB Gold plus test in active tuberculosis patients. J Clin Tuberc Other Mycobact Dis 2021;23:100223. [PMID: 33665376 DOI: 10.1016/j.jctube.2021.100223] [Reference Citation Analysis]
6 Soni A, Guliani A, Nehra K, Mehta PK. Insight into diagnosis of pleural tuberculosis with special focus on nucleic acid amplification tests. Expert Rev Respir Med 2022. [PMID: 35728039 DOI: 10.1080/17476348.2022.2093189] [Reference Citation Analysis]
7 Xu Y, Yang Q, Zhou J, Zhou F, Hezhang Y, Gao Y, Shao L, Shi J, Ruan Q, Zhang W. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study. Microbiol Spectr 2022;:e0187021. [PMID: 35234509 DOI: 10.1128/spectrum.01870-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Shafeque A, Bigio J, Hogan CA, Pai M, Banaei N. Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence? J Clin Microbiol 2020;58:e01950-19. [PMID: 32493779 DOI: 10.1128/JCM.01950-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]